Prognostic markers for CLL - how do they help determine who gets which treatment?
Overview of 3 studies on CLL therapy: data on ibrutinib and a ROR1 inhibitor
How does an understanding of the microenvironment aid research in CLL?
Small molecule inhibitors for CLL: which to use, sequencing, switching and combinations
How the removal of macrophages from tissue can stop or slow down the progression of CLL